LOMBARDI, GEMMA
 Distribuzione geografica
Continente #
NA - Nord America 6.725
AS - Asia 6.027
EU - Europa 3.695
SA - Sud America 529
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 80
OC - Oceania 38
Totale 17.218
Nazione #
US - Stati Uniti d'America 6.582
HK - Hong Kong 2.634
RU - Federazione Russa 1.509
SG - Singapore 1.203
CN - Cina 1.071
IT - Italia 911
BR - Brasile 412
KR - Corea 352
IE - Irlanda 285
VN - Vietnam 283
PL - Polonia 180
SE - Svezia 173
DE - Germania 153
IN - India 132
FI - Finlandia 119
FR - Francia 115
GB - Regno Unito 86
CA - Canada 84
BD - Bangladesh 80
ID - Indonesia 65
JO - Giordania 55
AR - Argentina 45
AU - Australia 37
NL - Olanda 37
JP - Giappone 27
MX - Messico 27
AT - Austria 26
ES - Italia 26
IQ - Iraq 26
EC - Ecuador 20
ZA - Sudafrica 20
CO - Colombia 19
CH - Svizzera 16
NG - Nigeria 13
TR - Turchia 12
UZ - Uzbekistan 12
PK - Pakistan 11
UA - Ucraina 11
BJ - Benin 10
BG - Bulgaria 9
PY - Paraguay 9
VE - Venezuela 9
CI - Costa d'Avorio 8
CR - Costa Rica 8
MA - Marocco 8
PH - Filippine 8
BE - Belgio 7
KZ - Kazakistan 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
KE - Kenya 6
PE - Perù 6
TW - Taiwan 6
AZ - Azerbaigian 5
GR - Grecia 5
JM - Giamaica 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
EG - Egitto 4
IL - Israele 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
RS - Serbia 3
BY - Bielorussia 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
LT - Lituania 2
MK - Macedonia 2
MU - Mauritius 2
SN - Senegal 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
Totale 17.094
Città #
Hong Kong 2.563
Santa Clara 1.282
Ashburn 1.103
Singapore 927
Seoul 350
Hefei 348
Fairfield 338
Dallas 324
San Jose 323
Dublin 281
Chandler 203
Milan 184
Warsaw 179
Woodbridge 160
Council Bluffs 158
Beijing 157
Seattle 145
Houston 139
Cambridge 115
Los Angeles 111
Wilmington 105
Altamura 97
Ho Chi Minh City 95
Lawrence 95
Buffalo 93
Dearborn 86
Florence 85
Rome 82
The Dalles 82
Moscow 79
Lauterbourg 66
Ann Arbor 64
New York 63
Hanoi 59
Princeton 59
Kent 57
Jakarta 56
Mumbai 55
Munich 54
Boston 51
Helsinki 50
São Paulo 43
Shanghai 38
Melbourne 37
San Diego 37
Lappeenranta 36
Bremen 33
Phoenix 31
Frankfurt am Main 30
Naples 29
Pune 29
Orem 28
Toronto 26
Turku 24
Medford 23
Atlanta 20
Clifton 20
Turin 19
Paris 18
Tokyo 18
Boardman 17
Montreal 17
Nuremberg 17
Rio de Janeiro 17
Brooklyn 16
Chicago 16
Denver 16
Haiphong 16
West Jordan 16
Bengaluru 14
Abuja 13
Grottaferrata 13
Guangzhou 13
Palermo 13
Baghdad 12
Bern 12
Figino 12
Johannesburg 12
London 12
Stockholm 12
Bari 11
Belo Horizonte 11
Bologna 10
Cotonou 10
Norwalk 10
Vienna 10
Brasília 9
Catania 9
Chennai 9
Da Nang 9
Dhaka 9
Manchester 9
Miano 9
Philadelphia 9
Tashkent 9
Washington 9
Abidjan 8
Dong Ket 8
Falkenstein 8
Guayaquil 8
Totale 11.932
Nome #
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 2.307
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 408
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 346
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 265
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 236
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study 226
The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial 223
12-month survival in nonagenarians inside the Mugello study: on the way to live a century 220
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 219
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 219
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 211
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 211
Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI 206
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 204
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 201
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort 200
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 200
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 199
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 198
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study 198
Biomarkers study in atypical dementia: proof of a diagnostic work-up 198
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 197
Assessing Relationships between Physically Demanding Work and Late-Life Disability in Italian Nonagenarian Women Living in a Rural Area 194
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 193
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 192
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 191
Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study 190
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 189
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 188
Primary Progressive Aphasia: Natural History in an Italian Cohort 188
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 188
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 186
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 186
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 185
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 182
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 182
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 180
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 180
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 178
Predictors of Mortality in 433 Nonagenarians Inside the Mugello Study: A 10 Years Follow-Up Study 174
Education modulates brain maintenance in presymptomatic frontotemporal dementia 171
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 169
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 169
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 162
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 161
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 160
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 160
Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease 157
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 156
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 156
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 153
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 151
Distinct neuroanatomical correlates of neuropsychiatric symptoms in the three main forms of genetic frontotemporal dementia in the GENFI Cohort 150
Contribution of mother tongue on cognitive reserve of an Italian bilingual literature Professor 150
Differential early subcortical involvement in genetic FTD within the GENFI cohort 148
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 147
Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder 144
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences 143
Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients 142
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 140
Definition of Reliability and Validity of Sensor-Derived Measurements in Parkinson’s Disease Population: The Inertial Study 138
Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study 138
Design and implementation of a Stroke Rehabilitation Registry for the systematic assessment of processes and outcomes and the development of data-driven prediction models: The STRATEGY study protocol 137
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 136
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 134
Medical Information Extraction with NLPPowered QABots: a Real-World Scenario 133
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 132
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review 127
Emerging roles for high-density lipoproteins in neurodegenerative disorders 126
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 125
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 125
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint 124
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 122
Structural brain splitting is a hallmark of Granulin-related Frontotemporal Dementia 118
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 118
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 115
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 115
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 112
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment 112
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 112
Understanding the interplay between APO E polymorphism and cognition in the Italian oldest old: results from the "Mugello study" 108
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 103
Leukocyte-derived ratios are associated with late-life any type dementia: a cross-sectional analysis of the Mugello study 103
The Association Between Positive Amyloid-PET and Cognitive Decline Is Not Always Supportive of Alzheimer’s Disease: Suggestions from a Case Report 95
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 94
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 93
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 93
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 92
Association between blood‑based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: a systematic review 92
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 88
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 85
Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia 83
null 63
Totale 17.218
Categoria #
all - tutte 48.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022401 0 0 38 17 6 21 9 47 31 24 85 123
2022/20231.182 99 258 64 84 53 193 176 76 134 6 20 19
2023/2024914 34 53 85 28 43 98 33 381 22 53 64 20
2024/20254.258 126 435 269 652 1.143 499 62 258 179 163 195 277
2025/20268.243 636 2.885 920 557 773 212 625 240 284 339 160 612
2026/2027727 161 239 327 0 0 0 0 0 0 0 0 0
Totale 17.218